Title : Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.

Pub. Date : 2015

PMID : 26089640






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our recent study has demonstrated that AT-101 enhanced the antitumor effect of cisplatin (CDDP) in a murine model of NSCLC via inhibition of the interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway. Cisplatin signal transducer and activator of transcription 3 Mus musculus
2 Our recent study has demonstrated that AT-101 enhanced the antitumor effect of cisplatin (CDDP) in a murine model of NSCLC via inhibition of the interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway. Cisplatin signal transducer and activator of transcription 3 Mus musculus